Fusion Pharmaceuticals Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q1 2021 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Fusion Pharmaceuticals Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q1 2021 to Q1 2024.
  • Fusion Pharmaceuticals Inc. Operating Lease, Right-of-Use Asset for the quarter ending March 31, 2024 was $17.9M, a 0.12% increase year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 $17.9M +$21K +0.12% Mar 31, 2024 10-Q 2024-05-07
Q4 2023 $18.6M +$12.9M +227% Dec 31, 2023 10-Q 2024-05-07
Q3 2023 $19.5M +$13.5M +227% Sep 30, 2023 10-Q 2023-11-07
Q2 2023 $17.6M +$11.4M +182% Jun 30, 2023 10-Q 2023-08-08
Q1 2023 $17.8M +$11.3M +173% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 $5.68M -$802K -12.4% Dec 31, 2022 10-K 2024-03-20
Q3 2022 $5.97M -$974K -14% Sep 30, 2022 10-Q 2022-11-08
Q2 2022 $6.26M -$965K -13.4% Jun 30, 2022 10-Q 2022-08-09
Q1 2022 $6.54M +$5.64M +627% Mar 31, 2022 10-Q 2022-05-10
Q4 2021 $6.49M Dec 31, 2021 10-K 2023-03-16
Q3 2021 $6.95M Sep 30, 2021 10-Q 2021-11-09
Q2 2021 $7.22M Jun 30, 2021 10-Q 2021-08-10
Q1 2021 $900K Mar 31, 2021 10-Q 2024-05-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.